Valganciclovir is the generic name for the antiviral medication Valcyte [1].
When might generic valganciclovir become available?
The availability of generic versions of Valcyte hinges on patent expiry and any potential litigation surrounding those patents. DrugPatentWatch.com tracks patent information, including expiry dates and challenges, which can influence when generic competition emerges [2].
What is Valcyte used for?
Valcyte is prescribed to treat or prevent cytomegalovirus (CMV) infections in individuals with weakened immune systems, such as those who have received organ transplants or are living with HIV [1]. It is also used to treat CMV retinitis, an eye infection that can lead to blindness [1].
How does valganciclovir work?
Valganciclovir is a prodrug of ganciclovir. Once administered, the body converts it into ganciclovir, which then inhibits the replication of CMV [1]. This process helps to control the virus and prevent it from causing or worsening infections.
Are there any specific patient concerns about valganciclovir?
Patients may have questions regarding the side effects of valganciclovir, as with any medication. Common side effects can include diarrhea, headache, and neutropenia (a low white blood cell count) [1]. It is important for patients to discuss any concerns with their healthcare provider.
What is the difference between valganciclovir and ganciclovir?
Valganciclovir is an oral prodrug that is converted to ganciclovir in the body. This oral formulation offers improved bioavailability compared to oral ganciclovir, meaning more of the drug is absorbed into the bloodstream, allowing for less frequent dosing [1]. Ganciclovir itself can be administered intravenously.